The industry’s concerns regarding disposable products continue to center on how leachables and extractables associated with disposables may affect their specific project or system. Further, over half of respondents indicated that they would restrict their usage of disposables if forced to rely on a single vendor.
Standardization could improve the overall rate of adoption for these products. Downstream disposables are moving toward greater industry acceptance in most manufacturing areas. Once this is achieved, more companies, both CMOs and biotherapeutic developers, are likely to increase use of disposable technologies as they increase their ability to fully integrate overall production processes.
This study suggests that, as new biomanufacturers and new products enter the industry and products pipeline, disposable options are becoming a fundamental part of the decision process.